EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME

The Lancet

Volumn 332, Issue 8624, 1988, Pages 1335-1338

  Rabelink, A J ^a   Erkelens, D W ^a   Hene R J ^a   Joles, J A ^a   Koomans, H A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; SIMVASTATIN;

CLINICAL ARTICLE; HUMAN; HYPERLIPIDEMIA; NEPHROTIC SYNDROME; PRIORITY JOURNAL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTYRAMINE; CLINICAL TRIALS; DRUG EVALUATION; FEMALE; HUMAN; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIA; LIPOPROTEINS; LIPOPROTEINS, LDL CHOLESTEROL; LOVASTATIN; MALE; MIDDLE AGE; NEPHROTIC SYNDROME; RANDOM ALLOCATION; SIMVASTATIN;

EID: 0024227363     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)90870-7     Document Type: Article

References (32)

1. The hyperlipidemia of nephrotic syndrome: Relation to plasma albumin concentration, oncotic pressure, and viscosity
2. Metabolic abnormalities in nephrotic syndrome: pathophysiology and complications
3. Population studies
4. Status of the coronary arteries in the nephrotic syndrome (analysis of 20 necropsy patients aged 15 to 35 years to determine if coronary atherosclerosis is accelerated)
5. The nephrotic syndrome and ischaemic heart disease
6. Focal and segmental glomeruloscleorsis: analogies to atherosclerosis
7. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy Model of chronic renal failure
8. Treatment of hyperhpidemia reduces glomerular injury in obese Zucker rats
9. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation
10. Treatment of the hyperlipidemia of the nephrotic syndrome a controlled trial
11. Effect of probucol on hyperlipidemia in patients with nephrotic syndrome
12. Hypercholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia
13. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia
14. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus
15. Enzymatische Bestimmung der gesamtcholesterins in Serum
16. Manual and semi-automated procedures for measurement of triglycerides in serum
17. Cholesterol determination in high density lipoproteins separated by three different methods
18. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein
19. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
20. Light-scattering immunoassay for specific proteins: a review
21. Serum cholesterol levels in the Netherlands as compared with those in the United States
22. Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia
23. New developments in lipid-lowering therapy. the role of inhibitors of hydroxymethylglutaryl coenzyme A reductase
24. High density lipoproteins and atherosclerosis
25. Complications during clofibrate treatment of nephrotic syndrome hyperlipoproteinaemia
26. Lovastatin therapy in nephrotic hyperlipidemia Effects on lipoprotein metabolism
27. Lipoprotein metabolism in experimental nephrosis
28. Studies on the turnover of triglyceride and esterified cholesterol in subjects with a nephrotic syndrome
29. Catabolism of very low density lipoproteins in experimental nephrosis
30. Mevinolin and colestipol stimulate receptor mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes
31. Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism
32. The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat